Dong Geng

2.7k total citations
22 papers, 356 citations indexed

About

Dong Geng is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dong Geng has authored 22 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Dong Geng's work include CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (6 papers) and Respiratory viral infections research (2 papers). Dong Geng is often cited by papers focused on CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (6 papers) and Respiratory viral infections research (2 papers). Dong Geng collaborates with scholars based in United States, China and Belgium. Dong Geng's co-authors include Allen Schantz, Hugh M. Davis, Manoj Rajadhyaksha, Carrie Wagner, Gopi Shankar, Enrique Zudaire, Jordan M. Schecter, Jesús G. Berdeja, Syed Rizvi and Indrajeet Singh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dong Geng

22 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dong Geng United States	11	128	125	121	59	58	22	356
Jason Law United States	8	153 1.2×	56 0.4×	90 0.7×	17 0.3×	71 1.2×	20	358
Mara Oliveri Italy	9	111 0.9×	35 0.3×	124 1.0×	18 0.3×	83 1.4×	9	379
Pierre‐André Chavaillaz United States	7	238 1.9×	133 1.1×	45 0.4×	34 0.6×	21 0.4×	9	351
Xueyan Wang China	13	56 0.4×	90 0.7×	77 0.6×	18 0.3×	7 0.1×	54	449
Xin Yin China	8	29 0.2×	64 0.5×	99 0.8×	18 0.3×	14 0.2×	41	312
Lorenzo Iovino United States	10	86 0.7×	82 0.7×	71 0.6×	11 0.2×	56 1.0×	38	317
Stefanie Zenker Germany	9	199 1.6×	32 0.3×	201 1.7×	12 0.2×	14 0.2×	10	383
Jinghong Wan China	7	129 1.0×	29 0.2×	148 1.2×	14 0.2×	25 0.4×	8	334
Zhi Duan China	11	123 1.0×	93 0.7×	194 1.6×	60 1.0×	10 0.2×	30	421
Daisuke Koyama Japan	12	107 0.8×	201 1.6×	136 1.1×	5 0.1×	72 1.2×	41	485

Countries citing papers authored by Dong Geng

Since Specialization

Citations

This map shows the geographic impact of Dong Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Geng more than expected).

Fields of papers citing papers by Dong Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Geng. The network helps show where Dong Geng may publish in the future.

Co-authorship network of co-authors of Dong Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Geng. A scholar is included among the top collaborators of Dong Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Geng. Dong Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, S., Wenjie Wang, Yiyang Xu, et al.. (2025). Mechanistic data-informed multiscale quantitative systems pharmacology modeling framework enables the clinical translation and efficacy assessment of CAR-T therapy in solid tumors. Journal for ImmunoTherapy of Cancer. 13(10). e012331–e012331. 2 indexed citations

Zhen, David B., Ramya Thota, Dong Geng, et al.. (2023). A phase 1, open-label, dose escalation and expansion, multicenter study of claudin 18.2-targeted chimeric antigen receptor T-cells in patients with unresectable, locally advanced, or metastatic gastric, gastroesophageal junction, esophageal, or pancreatic adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). TPS480–TPS480. 5 indexed citations

Sands, Jacob, Adam J. Schoenfeld, Paul Schwarzenberger, et al.. (2023). 702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer. SHILAP Revista de lepidopterología. A797–A797. 4 indexed citations

Li, Jun, et al.. (2022). Expression of miR-4739 in Gastric cancer and its Relationship with Clinical Pathological Features of Patients. Frontiers in Surgery. 9. 897583–897583. 10 indexed citations

Munshi, Nikhil C., Bruno Paiva, Thomas G. Martin, et al.. (2022). Efficacy Outcomes and Characteristics of Patients with Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity after Treatment with Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1. Blood. 140(Supplement 1). 4652–4654. 4 indexed citations

Fu, Qiang, Nan Liu, Hongrui Guo, et al.. (2022). Multi-Band Polarization Imaging in a Harsh Sea Fog Environment. Applied Sciences. 13(1). 202–202. 3 indexed citations

Agha, Mounzer, Adam D. Cohen, Yaël C. Cohen, et al.. (2022). MM-153 Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial Therapy. Clinical Lymphoma Myeloma & Leukemia. 22. S408–S409. 1 indexed citations

Gao, Xinliu, Cindy Chen, Dong Geng, et al.. (2021). Volumetric absorptive microsampling (VAMS®) in therapeutic protein quantification by LC-MS/MS: Investigation of anticoagulant impact on assay performance and recommendations for best practices in method development. Journal of Pharmaceutical and Biomedical Analysis. 196. 113895–113895. 11 indexed citations

Chen, Meili, Junzheng Wang, Yun Zhang, et al.. (2021). Preclinical analysis of an autologous CD4-targeted chimeric antigen receptor T-cell (CAR-T) immunotherapy for relapsed or refractory peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma (CTCL).. Journal of Clinical Oncology. 39(15_suppl). e14510–e14510. 3 indexed citations

10.

Berdeja, Jesús G., Deepu Madduri, Saad Z. Usmani, et al.. (2020). Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 38(15_suppl). 8505–8505. 63 indexed citations

11.

Fan, Xiao-Hu, et al.. (2019). Preclinical assessment of LCAR-B38M, a novel BCMA-targeting chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e160–e160. 6 indexed citations

12.

Zudaire, Enrique, Deepu Madduri, Saad Z. Usmani, et al.. (2019). Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R MM), Indicates Preferential Expansion of CD8+ T Cell Central Memory Cell Subset. Blood. 134(Supplement_1). 928–928. 23 indexed citations

13.

Maas, Brian M., Antonios O. Aliprantis, Kalpit A. Vora, et al.. (2018). 1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development. Open Forum Infectious Diseases. 5(suppl_1). S424–S425. 10 indexed citations

14.

Aliprantis, Antonios O., Luzelena Caro, Brian M. Maas, et al.. (2018). 1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects. Open Forum Infectious Diseases. 5(suppl_1). S572–S572. 7 indexed citations

15.

Liu, Huan, Fangfang Yu, Fengshi Chen, et al.. (2017). Associations Between Selenium Content in Hair and Kashin-Beck Disease/Keshan Disease in Children in Northwestern China: a Prospective Cohort Study. Biological Trace Element Research. 184(1). 16–23. 39 indexed citations

16.

Townsend, Robert, Yun Shen, Dong Geng, et al.. (2013). Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients. Clinical Drug Investigation. 34(2). 117–126. 29 indexed citations

17.

Marshall, Deborah J., Lani R. San Mateo, Stephen G. McCarthy, et al.. (2005). Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine. Cancer Immunology Immunotherapy. 54(11). 1082–1094. 21 indexed citations

18.

Geng, Dong, Gopi Shankar, Allen Schantz, et al.. (2005). Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies. Journal of Pharmaceutical and Biomedical Analysis. 39(3-4). 364–375. 54 indexed citations

19.

Geng, Dong. (2000). The new progression of aircraft flying qualities specification. Flight Dynamics. 1 indexed citations

20.

Yamada, Kazuhiko, Karl L. Womer, Edmund P. Pillsbury, et al.. (2000). Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses. The Journal of Immunology. 164(6). 3434–3444. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact